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Background: Teas from the husk fiber of Cocos nucifera are used in the folk medicine to treat arthritis and other
inflammatory processes. Some works show that some varieties have biological activities. However, one of the main
variety of the species, C. nucifera var. typica, known in Brazil as “gigante”, was not studied yet. Thus, this study
evaluates if this variety has the anti-inflammatory and antimicrobial activities already reported in other varieties.
Methods: C. nucifera aqueous crude extract (10, 50, and 100 mg/kg) and the reference drugs morphine (1 mg/kg) and
acetylsalicylic acid (100 mg/kg) were evaluated in models of inflammation (formalin-induced licking and subcutaneous
air pouch). The antioxidant activity was evaluated by 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) photometric assay
and compared with those of the standards (quercetin, rutin, and ascorbic acid). The extract was also screened against
Candida albicans, Escherichia coli, Staphylococcus aureus, and methicillin-resistant Staphylococcus aureus (MRSA), in the
agar diffusion method. The minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) were
determined by the broth micro-dilution assay. Activities of combinations of the extract and antibiotics (methicillin or
vancomycin) against MRSA were evaluated using checkerboard assays.
Results: The extract significantly inhibited the time that the animals spent licking the formalin-injected paws (second
phase). The extract also inhibited the inflammatory process induced by subcutaneous carrageenan injection by
reducing cell migration, protein extravasation, and TNF-α production. Additionally, the extract showed an antioxidant
potential in vitro as good as standards in their antioxidant activity. The extract was active only against S. aureus and
MRSA. MIC and the bactericidal concentrations were identical (1,024 μg/ml). The extract and methicillin acted
synergistically against the clinical MRSA isolate, whereas an indifferent effect was detected when the extract was
combined with vancomycin.
Conclusions: The extract exhibits anti-inflammatory activity through the inhibition of the cell migration. The mixture of
extract constituents and methicillin could lead to the development of a new combination antibiotic against MRSA
infections.
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The varieties of Cocos nucifera are found all over the
tropical regions. In Brazil, there are different varieties like
the “gigante” [1]. The aqueous crude extract of husk fiber
from C. nucifera is widely used in northeastern Brazilian
traditional medicine to treat diarrhea and arthritis [2].
During the past years, it has been shown that the “comum”* Correspondence: patricia.dias@icb.ufrj.br
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reproduction in any medium, provided the orC. nucifera has antibacterial, antiviral [2], antioxidant [3],
anti-neoplastic [4,5], and anti-inflammatory activities [6].
The variety “anão” is divided in “green”, “yellow” and
“red”. The “mestiço” are known as segregated hybrids,
resulting from aleatory cross between diverse plants, and
thereby with unknown origin [1].
The inflammatory process is a complex phenomenon
from vascular tissues to harmful stimuli, such as pathogens,
damaged cells or irritants [7]. In this paper, the anti-
inflammatory action of an aqueous crude extract of husk
fiber from C. nucifera was assessed in two animal models.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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as novel second messengers that help regulate cellular
events like inflammation [8], the free radical scavenging
properties was either evaluated.
Besides the antioxidant and anti-inflammatory activities,
the antimicrobial action was also evaluated by antibacterial
and antifungal activities assays in this study, once the
antimicrobial properties of the aqueous extracts of
husk fiber from another Brazilian and Nigerian C. nucifera
varieties were previously described [2,9]. Since combination
therapies may results in the administration of a lower dose
of commercial antimicrobials, which might reduce drug
toxicity and improve efficacy [10], combinations of the C.
nucifera extract and commercial antimicrobials were also
performed in this paper.
Considering that previous studies demonstrated the
low toxicity of aqueous crude extract of husk fiber from
other varieties of C. nucifera [3,6], this is also expected
for the “gigante” variety. In the popular use of this
plant extract, the occurrence of adverse effects is not
documented and aqueous crude extracts generally
have low acute toxicities [11].
Furthermore, the use of the husk fiber might lead to the
production of novel low-cost therapies and adjunct
treatments because it is a by-product from the processing
of C. nucifera [6]. Therefore, the purpose of this study
was to evaluate the anti-inflammatory, antioxidant
and antibacterial activities of a variety of C. nucifera that
has not been investigated yet, the “gigante”.
Materials and methods
Plant material
C. nucifera (Arecaceae) var. typica, commonly known as
“gigante”, was collected in Sergipe, Brazil (Campo
Experimental de Itaporanga, Embrapa Tabuleiros Costeiros)
and authenticated by the forest engineer Humberto
Rollemberg Fontes (Fitotecnia researcher). The charac-
terization and identification of this variety was done
following morphological, phenological, and production
aspects of the plant, in addition to other criteria,
such as age of the plant [12]. A voucher specimen
was deposited (number ASE- 27,441) at the Federal
University of Sergipe.
Preparation of C. Nucifera crude extract
The water extract from husk fiber was prepared by infu-
sion, as described previously [2]. The use of aqueous extract
was in accordance with the popular medicinal knowledge.
The extract was filtered, lyophilized and stored at −20oC,
yielding around 10% of the dry weight of starting material.
For the experiments described below, the aqueous crude
extract was re-suspended in distilled water. In the case of
the antimicrobial assays, it was sterilized by filtration
using a 0.22 μm membrane.Phytochemical composition
The lyophilized crude aqueous extract was submitted to
HPLC/DAD analyses, according to a protocol devised by
Peng et al. [13] to analyze procyanidins in grape seeds.
Samples (20 μl) were loaded onto a 4.6 x 250 mm
reverse phase RP-18 column (250 mm X 4,6 mm X 5 μm;
XTerra®). Elution was achieved with solvents A (0.02%
phosphoric acid in water) and B (82% acetonitrile, 0.04%
phosphoric acid) as follows: 0 to 15% solvent B in the first
15 min, 15 to 16% from 15 to 40 min, 16 to 17% from 40
to 45 min, 17 to 43% from 45 to 48 min, 43 to 52% from
48 to 49 min, held isocratic at 52% from 49 to 56 min,
reduced from 52 to 43% from 56 to 57 min, and from 17
to 0% from 58 to 60 min. Peaks were detected at 280 nm.
The concentration of procyanidins in the sample solution
of C. nucifera lyophilized crude aqueous extract was deter-
mined by the vanillin-HCl assay [14]. Briefly, 2.5 ml of
methanol (control) or 1% vanillin solution in methanol
(sample) and 2.5 ml of 9 M HCl in methanol was added
to a test tube containing 1 ml of catechin solution (0 to
300 μg/ml in methanol) or test solution (150 to 250 μg/ml
polyphenols in methanol). The reaction mixture was incu-
bated for 20 min at 30°C, and the absorbance at 500 nm
was measured. The absorbance was calculated as follows
for each standard and sample solution: a calibration curve
was prepared using the calculated absorbance for the
catechin solution, and the total procyanidin in each test
solution was calculated from the calibration curve.
Animals
All experiments were performed with male Swiss
mice (20–25 g) obtained from our own animal facility.
Animals were maintained in temperature-controlled room
(22±2°C) with a 12 h light/dark cycles and free access to
food and water. Twelve hours prior to each experiment,
the animals received only water in order to avoid food
interfering with the substance absorption. Animal care and
research protocols (ICBDFBC-015) were in accordance
with the principles and guidelines adopted by the Brazilian
College of Animal Experimentation (COBEA), approved by
the Ethical Committee for Animal Research (Biomedical
Science Institute/UFRJ).
Drugs and extract administration
Acetylsalicylic acid (ASA) and morphine hydrochloride
were purchased from Sigma (St. Louis, MO, USA) and
Merck Inc. (Brazil), respectively. They were dissolved in
sterile water just before use. The extract was dissolved in
sterile water and administered by oral gavage at doses
of 10, 50, and 100 mg/kg in a final volume of 0.1 ml.
Morphine (1 mg/kg) and ASA (100 mg/kg) were used
as reference drugs and were also administered by oral
gavage. The negative control group received vehicle
by oral gavage.
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The formalin test was conducted in a manner similar to
that described by Gomes et al. [15]. Animals received an
injection of 20 μl of formalin (2.5% v/v) into the dorsal
surface of the left hind paw. The time that the animal spent
licking the injected paw was recorded. The response
consists of two phases. The first phase occurs 5 min imme-
diately following the formalin injection (neurogenic pain
response), and the second phase occurs 15–30 min after
formalin injection (inflammatory pain response). The
animals were pretreated with oral doses of extract,
ASA, morphine or vehicle 60 min before the injection
of formalin.Subcutaneous air pouch (SAP) model
The method was similar to that described by Romano et al.
[16] with several modifications described in Raymundo
et al. [17]. Briefly, air pouches were produced by subcuta-
neous injection of sterile air (10 ml) into the intrascapular
region of the mice. After three days, another injection of
air (10 ml) was performed in order to maintain the
pouches. Three days after the last injection of air, animals
received an injection of sterile carrageenan suspension
(1%) into the SAP. Mice were pre-treated with oral doses
of extract, ASA or vehicle 1 h before and 23 h after carra-
geenan injection in the SAP. Animals were sacrificed 24 h
after carrageenan injection and the cavity was washed with
1 ml of sterile PBS. The total number of cells was deter-
mined with the aid of a haemocytometer. The exudates
were centrifuged at 170 x g for 10 min at 4°C, and the
supernatants were collected and stored at −20°C to further
analysis. Supernatants from exudates collected in the SAP
were used to measure tumor necrosis factor-α (TNF-α)
and protein. TNF-α was quantified by enzyme-linked
immunosorbent assay (ELISA), using the protocol supplied
by the manufacturer (B&D, USA). The protein content of
each supernatant was determined using the BCA method
(BCATM Protein Assay Kit, Pierce).Antioxidant activity determined by the 2,2-diphenyl-1-
picryl-hydrazyl-hydrate (DPPH) photometric assay
The free radical scavenging activity of the C. nucifera
extract was evaluated as described by Mensor et al.
[18]. Briefly, the plant extract was mixed with a 0.3
mM 2,2-Diphenyl-1-picryl-hydrazyl-hydrate (DPPH)
ethanol solution, to give final concentrations of 0.78,
1.56, 3.13, 6.25, 12.5, 25, 50, and 100 μg of extract
per ml of DPPH solution. After 30 min at room
temperature, the absorbance values were measured at
518 nm and converted into the percentage of antioxidant
activity. Free radical scavenging activity of the extract
was compared with those of the quercetin, rutin, and
ascorbic acid.Microorganisms and antimicrobial standards
Methicillin and vancomicin were obtained from Sigma-
Aldrich (Brazil) and stored according to the supplier’s
instructions. The following reference strains were used:
Staphylococcus aureus ATCC 6538 and the fungus
Candida albicans ATCC 36802. The study also included
a methicillin-resistant Staphylococcus aureus strain (BMB
9393) and a clinical isolate of Escherichia coli obtained
from University Hospital of the Federal University of
Rio de Janeiro.
Antimicrobial activities
The antimicrobial activity of the C. nucifera extract was
evaluated by the agar diffusion method described by Hili
et al. [19]. Microorganisms (2 x 105 cells) were spread over
appropriate plate (Brain Heart Infusion agar for bacteria
and Sabouraud agar for the fungus). The extract was
diluted in water (10 mg/ml), sterilized by filtration, and
10 μl aliquots of aqueous crude extract were applied to
newly inoculated plates. Plates were incubated at 37°C for
24 h (bacteria) or for 48 h at room temperature (fungus).
Minimal inhibitory concentration (MIC) and minimal
bactericidal concentration (MBC) assays
The MICs values of the extract against the test microor-
ganisms were determined by broth microdilution method
as recommended by CLSi [20]. The microdilution method
was also used to determine MBC values. The substances
were transferred to a microplate in order to obtain two-
fold serial dilutions of the original substance. Then, an
inoculum (10 μl) containing 5×106 CFU/ml was added to
each well and the microplates were aerobically incubated
at 37°C for 24 h. Wells without inoculum added were used
for sterility control, and the positive controls comprised of
inoculated growth medium without the substances.
Bacterial growth was indicated by the presence of turbid-
ity and a pellet on the well bottom, which was confirmed
with 30 μl of resazurin (Sigma-Aldrich) added aseptically
and incubated at 37°C for 1 h. The MIC was defined as the
lowest extract concentration that was able to completely
inhibit the bacterial growth. Methicillin and vancomicin
were used as antimicrobial standards.
To evaluate whether the action of the extract was
microbiostatic or microbicidal, 20 μl of the microbial
culture were removed from wells with concentrations
equal to, or higher than, the MIC, inoculated on BHI
agar plates, and incubated at 37°C for 24 h. The MBC
was defined as the lowest extract concentration at which
all of the bacteria have been killed.
Synergistic activity of the extract and antimicrobial drugs
against microorganisms
According to Mahboubi and Bidgoli [21], synergistic
antimicrobial activity was evaluated by a checkerboard
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and commercial antimicrobials were combined in
concentrations lower than their individual MIC values
by serial dilution in microplates. An inoculum (10 μl)
containing 5×106 CFU/ml was added to each well and
the microplates were incubated at 37°C for 24 h. The
visual bacterial growth was confirmed with 30 μl of
resazurin (Sigma-Aldrich) added aseptically and incubated
at 37°C for 1 h.
Fractional inhibitory concentrations (FICs) were calcu-
lated as the MIC of the combination of the extract and a
commercial antimicrobial divided by the MIC achieved
when one of them was used individually. FIC index is
widely accepted for use in evaluating in vitro synergistic
actions. It is the sum of FICs values and indicates the
nature of an interaction between two compounds. A FIC
index between 0.5 and 4.0 indicates an insignificant
interaction, whereas FIC index values <0.5 and >4.0 have
synergistic and antagonistic interactions, respectively.
Statistical analysis
In vitro experiments (antimicrobial and antioxidant
assays) were undertaken in triplicate sets. All animal
groups were composed of 6–10 mice and the results are
presented as the mean ± S.D. Statistical significance
between groups was determined by analyses of variance
(ANOVA) followed by Bonferroni’s test. p values less
than 0.05 (*p< 0.05) were considered significant.
Results and discussion
Phytochemical composition
Application of the reverse phase C18 HPLC protocol
devised by Peng et al. [13] to the crude aqueous extract
produced the chromatogram shown in Figure 1. The broad
peak at 50–55 min belongs to a mixture of polymericFigure 1 A trace of reverse phase HPLC analysis of C. nucifera lyophil
polymeric procyanidins.procyanidins. This elution behavior and UV absorp-
tion characteristics indicate the presence of condensed
tannins [13].
In order to corroborate the presence of these tannins,
the vanillin-HCl assay was performed. This test is highly
specific for procyanidins and involves acidic hydrolysis
of the condensed tannins followed by coupling of the
flavanol units to vanillin. Polymeric procyanidins were
detected at a concentration of 103.80 ± 10.5 mg/g of
aqueous extract.
Anti-inflammatory activity
Initially, the anti-inflammatory effect of the extract was
evaluated by the formalin-induced licking model. The
response consists of two phases and can evaluate both
antinociceptive and anti-inflammatory activities. Centrally
acting drugs, such as narcotics, are able to inhibit the two
phases equally. The first phase involves direct chemical
stimulation of nociceptive afferent fibers, leading to acute
neurogenic pain. However, the second phase involves
inflammation in the paw and central sensitization [22,23].
As depicted in Figure 2, extract treatment did not
reduce the time that the animal spent licking the formalin-
injected paw during the first phase (neurogenic pain
response). However, during the second phase (inflammatory
pain response), extract treatment induced dose-dependent
inhibition, indicating an anti-inflammatory effect. Therefore,
the extract could be acting through inhibition of the forma-
tion and/or liberation of inflammatory mediators or by
directly blocking its receptor. In order to evaluate how the
extract could inhibit the inflammatory reaction, another
model of inflammation was performed, the subcutaneous
air pouch. This model was not achieved by previous studies
with aqueous extract of husk fiber from C. nucifera. In this
model, subcutaneous injections of air into the back result inized crude aqueous extract. The asterisk (*) in the figure indicates
Figure 2 Effects of the C. nucifera extract on formalin-induced licking in mice. Animals were pretreated by oral administration different
doses of the C. nucifera extract, morphine (1 mg/kg), or vehicle. The results are presented as mean ± S.D. (n = 6–10) of the time that the animals
spent licking the formalin-injected paws. Statistical significance was calculated by ANOVA followed by Bonferroni’s test. * indicates p < 0.05 when
comparing to the vehicle-treated group.
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tion of carrageenan in this cavity induces inflammation.
The site serves as a reservoir of cells and mediators that can
be measured in the locally accumulating fluid [24].
Injection of carrageenan (1%) into the mice air pouches
increased the number of leukocytes that migrated to the
cavity when compared to the control that received PBS in
the SAP. Pre-treatment with lower dose of the extract
(10 mg/kg) was not able to significantly reduce the
number of leukocytes. However, pre-treatment withFigure 3 Effect of the C. nucifera extract in the subcutaneous
air pouch (SAP) model. Animals were pretreated by oral
administration with different doses of the extract 24 h and 1 h prior
to carrageenan (1%) injection into the SAP. The results are presented
as mean ± S.D. (n = 6–10) of total leukocytes (×106/ml). Statistical
significance was calculated by ANOVA followed by Bonferroni’s test.
* indicates p < 0.05 when comparing C. nucifera-treated mice with
the vehicle-treated group; # indicates p < 0.05 when comparing
vehicle-treated mice to the PBS-treated group.the other doses of extract (50 or 100 mg/kg) significantly
suppressed the cell migration (Figure 3).
A similar pattern was observed in the exudates protein
concentrations. An increase in the levels of protein was
detected following carrageenan injection in the SAP. This
carrageenan-induced protein leakage was significantly
inhibited by pre-treatment with the higher doses of extract
(50 or 100 mg/kg) (Figure 4). These effects could be due
to disruption of inflammatory mediators’ formation or by
inhibition of receptor function.
One of the mediators that play an important role in the
inflammatory process is TNF-α. It is released fromFigure 4 Effect of the C. nucifera extract on protein leakage and
TNF-α production. Animals were pretreated by oral administration
with different doses of the extract 24 h and 1 h prior to carrageenan
(1%) injection into the subcutaneous air pouch (SAP). The results are
presented as mean ± S.D. (n = 6–10) of protein (μg/ml) or TNF-α (pg/ml).
Statistical significance was calculated by ANOVA followed by Bonferroni’s
test. * indicates p < 0.05 when comparing C. nucifera-treated mice with
the vehicle treated group; # indicates p < 0.05 when comparing
vehicle-treated mice with the PBS-treated group.
Figure 5 Free radical scavenging properties of the C. nucifera
extract, using the DPPH photometric assay. The results are
presented as mean ± S.D. from three independent assays. EC50
values were determined.
Table 2 Minimal inhibitory concentrations (MICs) of C.





S. aureus 1024 0,25 nd
MRSA 1024 512 1
* All MICs were microbicidal; MET - methicillin; VCM - vancomycin; nd - not
determined.
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vascular endothelial permeability [25]. The production of
this mediator was dramatically increased by the injection
of carrageenan in the SAP. Nevertheless, the levels of this
mediator in the exudates were significantly reduced in
mice that received pre-treatment with the highest dose of
extract (100 mg/kg) (Figure 4).
In vitro antioxidant activity
The antioxidant activity was determined by the 2,2-
diphenyl-1-picryl-hydrazyl-hydrate (DPPH) assay. The
EC50 values were calculated, and the result obtained
for the C. nucifera extract was comparable with those
of the standards (quercetin, rutin, and ascorbic acid)
(Figure 5).
A good antioxidant effect of the aqueous crude
extract of husk fiber from “olho de cravo” C. nucifera
has already been determined by the same model
(EC50= 10.0 ± 0.7 μg/ml). This activity could be
attributed to the presence of condensed tannins in
the husk fiber from C. nucifera [11].
Nevertheless, the extrapolation of an antioxidant







(-) no activity; (+) activity.direct antioxidant activity of flavonoids in vivo is
likely to be limited to tissues in which relatively high
concentrations of these compounds could be achieved, like
in the digestive tract. In lower concentrations, they could
support indirect antioxidant actions, like regulation of
pro-oxidant enzymes and inhibition of protein–receptor
coupling that initiates oxidant production [26].
However, the antioxidant activity can be related to an
anti-inflammatory effect. Free radicals can attract inflamma-
tory mediators contributing to a generalized inflammatory
response [27]. The reactive oxygen species are linked
to increased endothelial permeability and leukocyte
transendothelial migration [28]. This can explain the
inhibition of the carrageenan-induced protein leakage
and the leukocyte migration by the extract of C.
nucifera in the SAP.Antimicrobial activity
The results of the agar diffusion assay showed that the
extract does not have an antimicrobial effect against the
fungus and the Gram-negative bacterium tested. However,
an inhibition zone was observed when the extract was
tested against S. aureus and MRSA (Table 1).
Esquenazi et al. [2] found that the “olho de cravo” C.
nucifera has activity against one S. aureus ATCC strain
and three clinical isolates of S. aureus. Further,
Akinyele et al. [9] studied the aqueous extracts of the
husk fiber from a C. nucifera variety from Nigeria.
They demonstrated that it also has activity against S.
aureus, in addition to inhibiting Gram-negative bacteria,
such as Escherichia coli.
In accordance to the lack of reported activity of C.
nucifera against Candida albicans in the literature, theTable 3 Effects of combinations of antimicrobial drugs
and C. nucifera extract against MRSA
MIC of drug in
combination








VCM 0,9375 256 0,9375 0,25 1,19 (I)
MET 96 256 0,1875 0,25 0,44 (S)
VCM - vancomicin; MET - methicillin; MIC - minimal inhibitory concentration
(μg/ml); FIC -fractional inhibitory concentration; I- indifferent; S – synergistic.
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Despite of being the same species of coconut, the different
varieties have different types and quantities of substances
in the fiber. The biological activity can be affected by
structural variations, such as stereochemistry [29].
This may be the reason why the “gigante” variety
does not have the same effects of the variety from
Nigeria described by Akinyele et al. [9]. In the
present paper, the extract does not possess growth
inhibitory activity against Escherichia coli. Nevertheless, it
is important to note that the tested strain is different
from that of the other study. Discrepancy in findings
may be the result of the pathogen strains utilized or
also be due to the variety of the plant and extraction
process used.
Others varieties have activity against S. aureus and the
“gigante” variety is likewise active. It was also investigated if
it would be able to inhibit the MRSA growth and it was.
Thus, the minimal inhibitory concentrations of the
extract against those bacteria (S. aureus and MRSA)
were determined and results are shown in Table 2.
MIC was the same for the two bacteria strains tested
(1024 μg/ml) and at this concentration, a microbicidal
effect was observed. MIC values were also determined
for methicillin. Methicillin-resistant staphylococcal is
defined as MIC ≥ 4 μg/ml [30]. To the methicillin-resistant
strain, vancomicin was used as standard antimicrobial.
Despite having been able to killing the two strains of
bacteria, the concentration of the extract was higher
than those of the standards antimicrobial used. How-
ever, the MIC must be interpreted in the appropriate
context. The raw extract is a mixture of active and
non-active compounds and therefore higher MICs are
expected [31].
Cos et al. [32] proposed an endpoint with concentration
required to produce 50% growth inhibition below
100 μg/ml for extracts. Nevertheless, in the present
study it was evaluated the extract’s concentration that
was able to completely inhibit the bacterial growth
and not only 50% growth inhibition. Thus, a higher
MIC is acceptable. Webster et al. [31] interpreted a
MIC value of crude plant extracts approximately to
1000 μg/ml as showing strong antifungal potential.
The antimicrobial activity may be enhanced by
synergistic effect of natural products and antimicro-
bial drugs. Therefore, the checkerboard assay was
performed to evaluate the antimicrobial effects of
combinations of antimicrobial drugs and the extract
against MRSA. When the extract was combined with
vancomycin, the MIC of the extract against MRSA
reduced 4-fold, however the MIC of vancomycin
against MRSA was almost the same. In this combination,
the FIC index was 1.19, corresponding to an indifferent
effect (Table 3).Nevertheless, the MIC value of methicillin against
MRSA was lowered from 512 to 96 μg/ml when the
extract was added at a concentration of 256 μg/ml
(4-fold reduction in MIC). This combination had a
FIC index calculated as 0.44, corresponding to a syn-
ergistic effect (Table 3). However, this synergistic
effect was not able to reverse the methicillin resistance
(MIC remained > 4 μg/ml).
The extract can be fractionated in order to check if
the activity improved. In addition, the active substances
in the extract and their modes of action should be
further investigated. Moreover, the extract can lead to
the development of novel inexpensive phytomedicines or
models for synthetic substances.
The antistaphylococcal effect of the extract is important
because MRSA and vancomycin-intermediate S. aureus
are spreading worldwide and the pharmaceutical arsenal
available to control antimicrobial-resistant bacteria is
limited. Invasive infections by S. aureus are associated with
significant morbidity and mortality, creating urgency in the
development of new therapies and adjunct treatments that
act against the resistant strains [33,34].Conclusions
Concerning the crude nature of the extract, the results
allow concluding that it exhibited significant bioactivity
and properties that support its uses in the folk medicine.
The extract exhibits anti-inflammatory activity through
the inhibition of the cell migration. In addition, the
mixture of extract constituents and methicillin could
lead to the development of a new combination antibiotic
against MRSA infections.
Although the modes of action remain to be completely
elucidated, the extract and its constituents might be
promising candidates for the direct or adjunct treatment
of inflammation and infection by MRSA, with low cost.
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